Relative hyperestrogenism in Klinefelter Syndrome: results from a meta-analysis
- 18 Downloads
Klinefelter Syndrome (KS) is classically described as characterized by hyperestrogenism, although solid evidence is lacking. This study aims to test the hypothesis that men with KS have higher serum estradiol than normal controls.
Meta-analysis of all studies extracted by MEDLINE from 1942 to 31 January 2018. All studies reporting serum estradiol measurement were considered, among them only case-control studies were included in the meta-analysis.
Meta-analysis was conducted according to the PRISMA statement using RevMan.
Out of 4120 articles, 23 case-control studies, 14 case series, and 19 case reports reported data on serum estradiol. A total of 707 KS and 1019 controls were included in the meta-analysis. Serum estradiol was slightly, but significantly higher in KS than controls (mean difference 4.25 pg/mL; CI: 0.41, 8.10 pg/mL; p = 0.030). This difference was lost considering only studies using estradiol assays with good accuracy (5.48 pg/mL, CI: −2.11, 13.07 pg/mL; p = 0.160). Serum testosterone and estradiol/testosterone ratio were significantly lower and higher in KS than controls, respectively. Data from KS case series and case reports confirmed that serum estradiol is within the normal ranges.
Serum estradiol is not increased in KS although slightly higher than controls. However, the meta-analysis that included only studies using a serum estradiol assay with good accuracy showed no difference in serum estradiol between KS and controls. The traditional belief that KS is associated with elevated serum estradiol should be reconsidered. This meta-analysis shows that men with KS have relative hyperestrogenism (increased estradiol/testosterone ratio) compared to controls.
KeywordsXXY aneuploidy Estrogens Sex steroids Male Estrogen to testosterone ratio Testosterone
Preliminary results of this work were presented at ENDO 2009 (Washington, DC, USA) in the Meet-the-Professor session on Clinical Issues in Management of Klinefelter’s Syndrome and summarized in the Meet-the-Professor and Case Management Forum Handouts.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants performed by any of the authors.
- 1.H.F. Klinefelter, E.C. Reifenstein, F. Albright, Syndrome characterized by gynecomastia, aspermatogenesis without Leydigism, increased excretion of follicle stimulating hormone. J. Clin. Endocrinol. 2, 615–627 (1942)Google Scholar
- 2.C.M. Smyth, W.J. Bremner, Klinefelter syndrome. Arch. Intern. Med. 158(12), 1309–1314 (1998)Google Scholar
- 4.C.H. Gravholt, S. Chang, M. Wallentin, J. Fedder, P. Moore, A. Skakkebaek, Klinefelter syndrome—integrating genetics, neuropsychology and endocrinology. Endocr. Rev. (2018). https://doi.org/10.1210/er.2017-00212
- 5.K.L. Becker, D.L. Hoffman, L.O. Underdahl, H.L. Mason, Klinefelter’s syndrome. Clinical and laboratory findings in 50 patients. Arch. Intern. Med. 118(4), 314–321 (1966)Google Scholar
- 6.C. Wang, H.W. Baker, H.G. Burger, D.M. De Kretser, B. Hudson, Hormonal studies in Klinefelter’s syndrome. Clin. Endocrinol. 4(4), 399–411 (1975)Google Scholar
- 7.W.A. Hsueh, T.H. Hsu, D.D. Federman, Endocrine features of Klinefelter’s syndrome. Medicine 57(5), 447–461 (1978)Google Scholar
- 8.J.S. Stewart, W.S. Mack, A.D. Govan, M.A. Ferguson-Smith, B. Lennox, Klinefelter’s syndrome: clinical and hormonal aspects. Q. J. Med. 28, 561–571 (1959)Google Scholar
- 9.G. Concolino, A. Marocchi, F. Sciarra, Plasma estrogens in bilateral gynecomastia. Folia Endocrinol. 22(2), 179–189 (1969)Google Scholar
- 10.J.L. Gabrilove, G.L. Nicolis, R.U. Hausknecht, Urinary testosterone, oestrogen production rate and urinary oestrogen in chromatin positive Klinefelter’s syndrome. Acta Endocrinol. 63(3), 499–504 (1970)Google Scholar
- 11.D.C. Sharma, J.L. Gabrilove, Biosynthesis of testosterone and oestrogens in vitro by the testicular tissue from patients with Klinefelter’s syndrome. Acta Endocrinol. 66(4), 737–744 (1971)Google Scholar
- 16.A. Kamischke, A. Baumgardt, J. Horst, E. Nieschlag, Clinical and diagnostic features of patients with suspected Klinefelter syndrome. J. Androl. 24(1), 41–48 (2003)Google Scholar
- 17.A. Bojesen, K. Kristensen, N.H. Birkebaek, J. Fedder, L. Mosekilde, P. Bennett, P. Laurberg, J. Frystyk, A. Flyvbjerg, J.S. Christiansen, C.H. Gravholt, The metabolic syndrome is frequent in Klinefelter’s syndrome and is associated with abdominal obesity and hypogonadism. Diabetes Care 29(7), 1591–1598 (2006). https://doi.org/10.2337/dc06-0145 Google Scholar
- 19.S. Chang, A. Skakkebaek, C. Trolle, A. Bojesen, J.M. Hertz, A. Cohen, D.M. Hougaard, M. Wallentin, A.D. Pedersen, J.R. Ostergaard, C.H. Gravholt, Anthropometry in Klinefelter syndrome—multifactorial influences due to CAG length, testosterone treatment and possibly intrauterine hypogonadism. J. Clin. Endocrinol. Metab., jc20142834 (2014). https://doi.org/10.1210/jc.2014-2834
- 20.S. Belli, D. Santi, E. Leoni, E. Dall’Olio, F. Fanelli, M. Mezzullo, C. Pelusi, L. Roli, S. Tagliavini, T. Trenti, A.R. Granata, U. Pagotto, R. Pasquali, V. Rochira, C. Carani, M. Simoni, Human chorionic gonadotropin stimulation gives evidence of differences in testicular steroidogenesis in Klinefelter syndrome, as assessed by liquid chromatography-tandem mass spectrometry. Eur. J. Endocrinol./Eur. Fed. Endocr. Soc. 174(6), 801–811 (2016). https://doi.org/10.1530/eje-15-1224 Google Scholar
- 21.A. Ferlin, R. Selice, S. Angelini, M. Di Grazia, N. Caretta, F. Cavalieri, A. Di Mambro, C. Foresta, Endocrine and psychological aspects of sexual dysfunction in Klinefelter patients. Andrology (2018). https://doi.org/10.1111/andr.12474
- 22.G. Forti, G. Giusti, A. Borghi, M. Pazzagli, G. Fiorelli, E. Cabresi, M. Mannelli, F. Bassi, P. Giannotti, S. Fusi, M. Serio, Klinefelter’s syndrome: a study of its hormonal plasma pattern. J. Endocrinol. Invest. 1(2), 149–154 (1978)Google Scholar
- 23.M. Wielgos, L. Bablok, S. Fracki, M. Czaplicki, L. Marianowski, The naloxone test in Klinefelter syndrome. Neuro. Endocrinol. Lett. 25(6), 438–442 (2004)Google Scholar
- 24.Z. Yesilova, M. Ozata, C. Oktenli, S.Y. Sanisoglu, M.K. Erbil, K. Dagalp, Effect of supraphysiologic doses of testosterone on fasting plasma total homocysteine concentrations in men with Klinefelter’s syndrome. Fertil. Steril. 81(5), 1278–1282 (2004). https://doi.org/10.1016/j.fertnstert.2003.11.029 Google Scholar
- 26.R. Selice, N. Caretta, A. Di Mambro, M. Torino, P. Palego, A. Ferlin, C. Foresta, Prostate volume and growth during testosterone replacement therapy is related to visceral obesity in Klinefelter syndrome. Eur. J. Endocrinol./Eur. Fed. Endocr. Soc. 169(6), 743–749 (2013). https://doi.org/10.1530/eje-13-0488 Google Scholar
- 27.D.A. Smith, M.S. Walker, Changes in plasma steroids and bone density in Klinefelter’s syndrome. Calcif. Tissue Res. 22(Suppl.), 225–228 (1977)Google Scholar
- 29.M. Ozata, M. Yildirimkaya, M. Bulur, K. Yilmaz, E. Bolu, A. Corakci, M.A. Gundogan, Effects of gonadotropin and testosterone treatments on Lipoprotein(a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism. J. Clin. Endocrinol. Metab. 81(9), 3372–3378 (1996). https://doi.org/10.1210/jcem.81.9.8784099 Google Scholar
- 34.J.L. Gabrilove, E.K. Freiberg, J.C. Thornton, G.L. Nicolis, Effect of age on testicular function in patients with Klinefelter’s syndrome. Clin. Endocrinol. 11(3), 343–347 (1979)Google Scholar
- 35.D. Meschede, J. Horst, Klinefelter Syndrome. In: J.H. Wass, S.M. Shalet (ed.), Oxford Textbook of Endocrinology and Diabetes, pp. 1292–1294 (Oxford University Press, Oxford, UK, 2002)Google Scholar
- 38.D. Santi, S. De Vincentis, S. Scaltriti, V. Rochira, Data from: Is serum estradiol really increased in Klinefelter Syndrome? Evidence of relative hyperestrogenism from a meta-analysis. Figshare (2018. Deposited 7 July 2018 https://doi.org/10.6084/m9.figshare.6790007.v1). https://doi.org/10.6084/m9.figshare.6790007.v1
- 39.J. Chandler, M. Clarke, J. Higgins. The Cochrane Collaboration. Cochrane Methods. (John Wiley & Sons Ltd, UK), 2012)Google Scholar
- 40.F. Eulry, B. Bauduceau, D. Lechevalier, J. Magnin, J. Flageat, D. Gautier, [Early spinal bone loss in Klinefelter syndrome. X-ray computed tomographic evaluation in 16 cases]. Rev. Rhum. (Ed. francaise: 1993) 60(4), 287–291 (1993)Google Scholar
- 41.F.Z. Stanczyk, J. Jurow, A.W. Hsing, Limitations of direct immunoassays for measuring circulating estradiol levels in postmenopausal women and men in epidemiologic studies. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology 19(4), 903–906 (2010). https://doi.org/10.1158/1055-9965.epi-10-0081 Google Scholar
- 42.H. Ketha, A. Girtman, R. Singh, Estradiol assays—the path ahead. Steroids (2014). https://doi.org/10.1016/j.steroids.2014.08.009
- 45.J.S. Lee, B. Ettinger, F.Z. Stanczyk, E. Vittinghoff, V. Hanes, J.A. Cauley, W. Chandler, J. Settlage, M.S. Beattie, E. Folkerd, M. Dowsett, D. Grady, S.R. Cummings, Comparison of methods to measure low serum estradiol levels in postmenopausal women. J. Clin. Endocrinol. Metab. 91(10), 3791–3797 (2006). https://doi.org/10.1210/jc.2005-2378 Google Scholar
- 46.A.W. Hsing, F.Z. Stanczyk, A. Belanger, P. Schroeder, L. Chang, R.T. Falk, T.R. Fears, Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive. Oncology 16(5), 1004–1008 (2007). https://doi.org/10.1158/1055-9965.epi-06-0792 Google Scholar
- 47.J. Reinsberg, O. Batz, T. Bertsch, N. Bewarder, W. Deschner, V. Drescher, M. Dronsek, M. Emami, R. Keller, M. Klemm, H.U. Koch, J. Meissner, T. Plecko, I. Schauer, A.M. Schweiger, A. Ullrich, H.M. van de Loo, M. Zwirner, Precision and long-term stability of different estradiol immunoassays assessed in a multi-center quality control study. Clin. Lab. 55(5-6), 201–206 (2009)Google Scholar
- 49.P.M. Sluss, F.J. Hayes, J.M. Adams, W. Barnes, G. Williams, S. Frost, J. Ramp, D. Pacenti, D.C. Lehotay, S. George, C. Ramsay, R.C. Doss, W.F. Crowley Jr., Mass spectrometric and physiological validation of a sensitive, automated, direct immunoassay for serum estradiol using the Architect. Clin. Chim. Acta; Int. J. Clin. Chem. 388(1–2), 99–105 (2008). https://doi.org/10.1016/j.cca.2007.10.020 Google Scholar
- 50.A. Barbarino, L. De Marinis, Klinefelter’s syndrome: effects of oestrogen on growth hormone, prolactin and thyrotrophin release, and on thyrotrophin and prolactin responses to thyrotrophin-releasing hormone. Acta Endocrinol. 92(2), 347–357 (1979)Google Scholar
- 52.R. Luboshitzky, O. Wagner, S. Lavi, P. Herer, P. Lavie, Abnormal melatonin secretion in hypogonadal men: the effect of testosterone treatment. Clin. Endocrinol. 47(4), 463–469 (1997)Google Scholar
- 53.G. Luisetto, I. Mastrogiacomo, G. Bonanni, G. Pozzan, S. Botteon, L. Tizian, P. Galuppo, Bone mass and mineral metabolism in Klinefelter’s syndrome. Osteoporos. Int. 5(6), 455–461 (1995)Google Scholar
- 54.C. Oktenli, Z. Yesilova, I.H. Kocar, U. Musabak, M. Ozata, A. Inal, D. Gul, Y. Sanisoglu, Study of autoimmunity in Klinefelter’s syndrome and idiopathic hypogonadotropic hypogonadism. J. Clin. Immunol. 22(3), 137–143 (2002)Google Scholar
- 55.P.A. Tomasi, R. Oates, L. Brown, G. Delitala, D.C. Page, The pituitary-testicular axis in Klinefelter’s syndrome and in oligo-azoospermic patients with and without deletions of the Y chromosome long arm. Clin. Endocrinol. 59(2), 214–222 (2003)Google Scholar
- 56.S. Belli, D. Santi, E. Leoni, E. Dall’Olio, F. Fanelli, M. Mezzullo, C. Pelusi, L. Roli, S. Tagliavini, T. Trenti, A.R.M. Granata, U. Pagotto, R. Pasquali, V. Rochira, C. Carani, M. Simoni, Human chorionic gonadotropin stimulation gives evidence of differences in testicular steroidogenesis in Klinefelter syndrome, as assessed by liquid chromatography–tandem mass spectrometry. Eur. J. Endocrinol. 174, 1–11 (2016). https://doi.org/10.1530/EJE-15-1224 Google Scholar
- 57.A. Bojesen, N. Birkebaek, K. Kristensen, L. Heickendorff, L. Mosekilde, J.S. Christiansen, C.H. Gravholt, Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos. Int. 22(5), 1441–1450 (2011). https://doi.org/10.1007/s00198-010-1354-7 Google Scholar
- 59.G. Bleau, C.L. Richer, A. Chapdelaine, K.D. Roberts, Hormone study in a case of Klinefelter syndrome with an isochromosome Xq. Int. J. Fertil. 32(1), 50–55 (1987)Google Scholar
- 60.C. Boucekkine, M. Semrouni, Presence of positive feedback in males with Klinefelter’s syndrome. Horm. Res. 33(6), 244–247 (1990)Google Scholar
- 61.V.H. Goh, K.O. Lee, Does a positive oestrogen feedback on the hypothalamic-pituitary axis exist concurrently with a defective testosterone feedback in Klinefelter’s syndrome? Horm. Res. 50(3), 160–165 (1998)Google Scholar
- 62.J.J. Stepan, P. Burckhardt, V. Hana, The effects of three-month intravenous ibandronate on bone mineral density and bone remodeling in Klinefelter’s syndrome: the influence of vitamin D deficiency and hormonal status. Bone 33(4), 589–596 (2003)Google Scholar
- 63.M. Zitzmann, M. Depenbusch, J. Gromoll, E. Nieschlag, X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J. Clin. Endocrinol. Metab. 89(12), 6208–6217 (2004). https://doi.org/10.1210/jc.2004-1424 Google Scholar
- 70.V.V. Shanbhogue, S. Hansen, N.R. Jorgensen, K. Brixen, C.H. Gravholt, Bone geometry, volumetric density, microarchitecture and estimated bone strength assessed by HR-pQCT in Klinefelter Syndrome. J. Bone Miner. Res. (2014). https://doi.org/10.1002/jbmr.2272
- 76.M.G. Forest, A. Lecoq, J.M. Saez, Kinetics of human chorionic gonadotropin-induced steroidogenic response of the human testis. II. Plasma 17 alpha-hydroxyprogesterone, delta4-androstenedione, estrone, and 17 beta-estradiol: evidence for the action of human chorionic gonadotropin on intermediate enzymes implicated in steroid biosynthesis. J. Clin. Endocrinol. Metab. 49(2), 284–291 (1979). https://doi.org/10.1210/jcem-49-2-284 Google Scholar
- 77.G.A. Kanakis, E. Nieschlag, Klinefelter syndrome: more than hypogonadism. Metabolism (2018). https://doi.org/10.1016/j.metabol.2017.09.017
- 79.V. Rochira, B. Madeo, C. Diazzi, L. Zirilli, S. Daniele, C. Carani, Estrogens and male reproduction. In: L.J. De Groot, G. Chrousos, K. Dungan, K.R. Feingold, A. Grossman, J.M. Hershman, C. Koch, M. Korbonits, R. McLachlan, M. New, J. Purnell, R. Rebar, F. Singer, A. Vinik (eds.), Endotext (MDText.com, Inc., South Dartmouth, MA, 2000)Google Scholar